vs

Side-by-side financial comparison of Canopy Growth Corp (CGC) and Orchid Island Capital, Inc. (ORC). Click either name above to swap in a different company.

Canopy Growth Corp is the larger business by last-quarter revenue ($54.4M vs $38.5M, roughly 1.4× Orchid Island Capital, Inc.). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs -84.0%, a 352.7% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs -0.3%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs 1.2%).

Canopy Growth Corporation, formerly Tweed Marijuana Inc., is a cannabis company based in Smiths Falls, Ontario.

Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.

CGC vs ORC — Head-to-Head

Bigger by revenue
CGC
CGC
1.4× larger
CGC
$54.4M
$38.5M
ORC
Growing faster (revenue YoY)
ORC
ORC
+372.9% gap
ORC
372.6%
-0.3%
CGC
Higher net margin
ORC
ORC
352.7% more per $
ORC
268.7%
-84.0%
CGC
Faster 2-yr revenue CAGR
ORC
ORC
Annualised
ORC
301.6%
1.2%
CGC

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CGC
CGC
ORC
ORC
Revenue
$54.4M
$38.5M
Net Profit
$-45.7M
$103.4M
Gross Margin
28.8%
Operating Margin
-35.3%
Net Margin
-84.0%
268.7%
Revenue YoY
-0.3%
372.6%
Net Profit YoY
48.6%
1764.9%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CGC
CGC
ORC
ORC
Q4 25
$54.4M
$38.5M
Q3 25
$48.7M
$26.9M
Q2 25
$52.7M
$23.2M
Q1 25
$47.5M
$19.7M
Q4 24
$54.6M
Q3 24
$46.0M
$340.0K
Q2 24
$48.3M
$-697.0K
Q1 24
$53.1M
$-2.5M
Net Profit
CGC
CGC
ORC
ORC
Q4 25
$-45.7M
$103.4M
Q3 25
$-1.2M
$72.1M
Q2 25
$-30.3M
$-33.6M
Q1 25
$17.1M
Q4 24
$-89.0M
Q3 24
$-93.7M
$17.3M
Q2 24
$-92.8M
$-5.0M
Q1 24
$19.8M
Gross Margin
CGC
CGC
ORC
ORC
Q4 25
28.8%
Q3 25
32.8%
Q2 25
25.0%
Q1 25
16.2%
Q4 24
32.2%
Q3 24
34.7%
Q2 24
34.8%
Q1 24
21.3%
Operating Margin
CGC
CGC
ORC
ORC
Q4 25
-35.3%
Q3 25
-25.3%
Q2 25
-31.4%
Q1 25
Q4 24
-31.9%
Q3 24
-72.9%
Q2 24
-44.0%
Q1 24
Net Margin
CGC
CGC
ORC
ORC
Q4 25
-84.0%
268.7%
Q3 25
-2.5%
267.8%
Q2 25
-57.6%
-145.0%
Q1 25
86.9%
Q4 24
-163.0%
Q3 24
-203.7%
5094.1%
Q2 24
-192.0%
714.3%
Q1 24
-794.2%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CGC
CGC
ORC
ORC
Cash + ST InvestmentsLiquidity on hand
$271.1M
$665.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$553.5M
$1.4B
Total Assets
$807.5M
$11.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CGC
CGC
ORC
ORC
Q4 25
$271.1M
$665.9M
Q3 25
$217.6M
$583.9M
Q2 25
$104.8M
$440.8M
Q1 25
$96.0M
$396.4M
Q4 24
$130.2M
Q3 24
$168.8M
$322.1M
Q2 24
$142.3M
$241.0M
Q1 24
$148.5M
$190.4M
Stockholders' Equity
CGC
CGC
ORC
ORC
Q4 25
$553.5M
$1.4B
Q3 25
$537.3M
$1.1B
Q2 25
$357.0M
$912.0M
Q1 25
$355.7M
$855.9M
Q4 24
$431.8M
Q3 24
$372.1M
$656.0M
Q2 24
$389.0M
$555.9M
Q1 24
$365.3M
$481.6M
Total Assets
CGC
CGC
ORC
ORC
Q4 25
$807.5M
$11.7B
Q3 25
$781.0M
$9.1B
Q2 25
$660.4M
$7.6B
Q1 25
$669.9M
$7.3B
Q4 24
$849.9M
Q3 24
$899.6M
$5.9B
Q2 24
$938.9M
$4.9B
Q1 24
$949.2M
$4.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CGC
CGC
ORC
ORC
Operating Cash FlowLast quarter
$120.4M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.16×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CGC
CGC
ORC
ORC
Q4 25
$120.4M
Q3 25
$28.0M
Q2 25
$-7.5M
$18.4M
Q1 25
$-121.0M
$25.8M
Q4 24
Q3 24
$-14.8M
Q2 24
$-37.8M
$19.3M
Q1 24
$-205.8M
$45.0M
Free Cash Flow
CGC
CGC
ORC
ORC
Q4 25
Q3 25
Q2 25
$-8.5M
Q1 25
$-128.9M
Q4 24
Q3 24
Q2 24
$-40.7M
Q1 24
$-208.3M
FCF Margin
CGC
CGC
ORC
ORC
Q4 25
Q3 25
Q2 25
-16.1%
Q1 25
-271.5%
Q4 24
Q3 24
Q2 24
-84.1%
Q1 24
-392.1%
Capex Intensity
CGC
CGC
ORC
ORC
Q4 25
Q3 25
Q2 25
1.8%
Q1 25
16.6%
Q4 24
Q3 24
Q2 24
5.9%
Q1 24
4.7%
Cash Conversion
CGC
CGC
ORC
ORC
Q4 25
1.16×
Q3 25
0.39×
Q2 25
Q1 25
1.51×
Q4 24
Q3 24
-0.86×
Q2 24
Q1 24
2.28×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CGC
CGC

Other$24.0M44%
Canadian Adult Use Cannabis$22.9M42%
International Markets Cannabis$6.2M11%
Other Geographical Area$1.2M2%

ORC
ORC

Segment breakdown not available.

Related Comparisons